Zhitong Finance App News, Osecon (002755.SZ) issued an announcement. Jiangsu Aosaikang Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for malibavir tablets approved and issued by the State Drug Administration. The drug is classified as a chemical drug in 4 categories. Obtaining the “Drug Registration Certificate” this time is regarded as passing the consistency evaluation, which will further expand the company's pipeline in the field of anti-infection and enhance the company's competitiveness in this field.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.